GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ping An Healthcare And Technology Co Ltd (HKSE:01833) » Definitions » Research & Development

Ping An Healthcare And Technology Co (HKSE:01833) Research & Development : HK$0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ping An Healthcare And Technology Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Ping An Healthcare And Technology Co's Research & Development for the six months ended in Jun. 2024 was HK$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0 Mil.

Ping An Healthcare And Technology Co Research & Development Historical Data

The historical data trend for Ping An Healthcare And Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ping An Healthcare And Technology Co Research & Development Chart

Ping An Healthcare And Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only - - - - -

Ping An Healthcare And Technology Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ping An Healthcare And Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ping An Healthcare And Technology Co  (HKSE:01833) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ping An Healthcare And Technology Co Research & Development Related Terms

Thank you for viewing the detailed overview of Ping An Healthcare And Technology Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Ping An Healthcare And Technology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ping An Healthcare And Technology Co Ltd (HKSE:01833) » Definitions » Research & Development
Comparable Companies
HKSE:02158 HKSE:09886 HKSE:02415 HKSE:02361 HKSE:06819 HKSE:09686 HKSE:02251 HKSE:02159 VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH TDOC PRVA
Traded in Other Exchanges
PANHF:USA PIAHY:USA 1XZ:Germany
Address
No. 298, Guo Xia Road, 5-9th Floor, Building B, INNO KIC, Yangpu District, Shanghai, CHN
Website
https://www.pagd.net
Ping An Healthcare and Technology is the parent of Ping An Good Doctor, or PAGD, an online platform offering healthcare services in the form of a health maintenance organization, or HMO, model that provides commercial healthcare services and offers healthcare checkup, healthcare management, and corporate reimbursement for a fee. The company leverages the network of health providers from its parent Ping An Group, where it enters into contracts with physicians, hospitals, and specialists to offer their services to HMO participants. Other than commercial healthcare premium services, PAGD offers online consultations and prescription e-commerce online to individuals. The platform has 1,748 corporate clients and 17.7 million paying users. PAGD is 38.43% owned by its parent company.
Executives
Sounda Properties Limited 2201 Interest of corporation controlled by you
Hopson Development Holdings Limited 2201 Interest of corporation controlled by you
Chu Mang Yee 2201 Interest of corporation controlled by you
Hsbc Holdings Plc 2302 Custodian
Morgan Stanley 2201 Interest of corporation controlled by you
Dou Wenwei 2201 Interest of corporation controlled by you
Wang Wenjun 2201 Interest of corporation controlled by you
Bang Qi Jian You Xian Gong Si 2101 Beneficial owner
Zhong Guo Ping An Bao Xian Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
An Ke Ji Shu You Xian Gong Si 2201 Interest of corporation controlled by you
An Xin You Xian Gong Si 2101 Beneficial owner

Ping An Healthcare And Technology Co Headlines

No Headlines